Enzymatic synthesis may be more sustainable for large-scale oligonucleotide manufacturing than traditional solid-phase techniques.
Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...